Moreover, additional data has established that anti-CTLA-4 therapy stimulates the activation and degranulation of NK cells in the tumor microenvironment (TME) in correlation with a depletion of intra-tumoral Tregs [26]. This evidence concerns the gene CTLA4 and neoplasm.